Anoop Misra1, Ambady Ramachandran2, Banshi Saboo3, Jothydev Kesavadev4, Arvind Sosale5, Shashank Joshi6, Ashok Kumar Das7. 1. Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, India; National Diabetes, Obesity and Cholesterol Foundation (N-DOC), India; Diabetes Foundation (India) (DFI), India. Electronic address: anoopmisra@gmail.com. 2. India Diabetes Research Foundation, Dr.A.Ramachandran's Diabetes Hospitals, Chennai, India. 3. Diacare, Diabetes Care & Hormone Clinic, Ahmedabad, India. 4. Jothydev's Diabetes Research Centers, Kerala, India. 5. Diacon Hospital, Bangalore, India. 6. Joshi Clinic and Lilavati Hospital, Mumbai, India. 7. Sri Aurobindo Heath System, New Medical Center, Pondicherry, India.
Abstract
BACKGROUND: Current guidelines state that screening for diabetes should be done at 30 years of age in India. METHODS: Investigators from multiple sites in India were involved in providing data regarding patients with type 2 diabetes (T2D) aged 30 years or less. Other relevant studies were also reviewed. RESULTS: Overview of published and unpublished data show increasing prevalence of T2D in individuals 30 years and less. About 3/4th of them had overweight/obesity. CONCLUSION: Screening for diabetes in India should start at 25 years in non-pregnant adults instead of 30 years as currently stipulated.
BACKGROUND: Current guidelines state that screening for diabetes should be done at 30 years of age in India. METHODS: Investigators from multiple sites in India were involved in providing data regarding patients with type 2 diabetes (T2D) aged 30 years or less. Other relevant studies were also reviewed. RESULTS: Overview of published and unpublished data show increasing prevalence of T2D in individuals 30 years and less. About 3/4th of them had overweight/obesity. CONCLUSION: Screening for diabetes in India should start at 25 years in non-pregnant adults instead of 30 years as currently stipulated.